CNC Maintained by Barclays -- Price Target Raised to $82.00
gurufocus.com · 2026-10-28
Centene Corp Analyst Rating Update - Overweight by Barclays On October 03, 2023, analyst Andrew Mok from Barclays maintained an "Overweight" rating for Cente
TickrTrends take: Barclays' decision to raise its price target for CNC to $82 while maintaining its rating suggests the analyst sees upside potential within current market conditions, though this must be weighed against TickrTrends' assessment that the stock is overvalued. For investors focused on valuation metrics, the gap between Barclays' target and TickrTrends' overvalued designation indicates divergent views on whether CNC's fundamentals justify its current trading level in the Healthcare sector. Tracking whether CNC moves toward or away from the $82 target may help clarify whether the market is repricing the company's intrinsic value or if valuation concerns persist.
Read the full story at gurufocus.com →
Is CNC undervalued? See TickrTrends' fair value analysis →